Three cross-sectional studies reported that higher adiponectin levels were associated with a reduced LF/HF ratio [28], reduced very-low-frequency (VLF) power [11] and higher odds of CAN [10] in individuals with type 2 diabetes, whereas a study based on an occupational sample (prevalence of diabetes 2.3%) observed no associations between adiponectin and HRV indices [29]. Here, ADIPOQ is linked to type 2 diabetes mellitus.